Justin joined Osage University Partners in 2024 as an Associate on the life sciences team. He focuses on biotech investment opportunities across therapeutic areas.

Prior to OUP, Justin was an Analyst at Octagon Capital Advisors, specializing in healthcare investments in oncology and immunology across public and private markets globally. Prior to Octagon, Justin worked in clinical operations at Axsome Therapeutics helping manage trials for Auvelity® in CNS disorders.

Justin holds an M.Sc. in clinical research from Icahn School of Medicine at Mount Sinai, where he gained expertise in clinical trial design, biostatistics, and interpretation of clinical trial results. He worked at Sinai BioDesign during graduate school, collaborating with physicians to identify clinical shortcomings and develop innovative medical device solutions. Justin also holds a B.A. in human health from Emory University.